REGENXBIO Inc. (NASDAQ:RGNX) is held by 174 institutional investors per 13F filings through March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 5,782,808 | 25,997 | 0.45% | $48,459,930.00 |
| Redmile Group, LLC | 31 Mar, 2026 | 4,368,804 | 0 | 0.00% | $36,610,578.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 3,483,800 | -69,702 | -1.96% | $27,069,126.00 |
| State Street Corp | 31 Mar, 2026 | 2,731,485 | 444,749 | 19.45% | $22,889,844.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,066,157 | 51,369 | 2.55% | $17,314,400.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,007,146 | 2,007,146 | 0.00% | $16,819,883.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,839,463 | -1,731,411 | -48.49% | $15,414,700.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 1,500,000 | 300,000 | 25.00% | $12,570,000.00 |
| Qube Research & Technologies Ltd | 31 Mar, 2026 | 1,310,493 | 867,803 | 196.03% | $10,981,931.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,137,498 | -7,708 | -0.67% | $9,534,835.00 |
| AQR CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,051,712 | -310,250 | -22.78% | $8,813,347.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 1,018,901 | 1,018,901 | 0.00% | $8,538,390.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 1,010,381 | 106,530 | 11.79% | $8,463,684.00 |
| Assenagon Asset Management S.A. | 31 Mar, 2026 | 980,611 | -179,769 | -15.49% | $8,217,520.00 |
| Nuveen, LLC | 31 Mar, 2026 | 582,016 | -76,494 | -11.62% | $4,877,294.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 554,892 | 424,951 | 327.03% | $4,649,995.00 |
| Pale Fire Capital SE | 31 Mar, 2026 | 493,726 | -5,800 | -1.16% | $4,137,424.00 |
| 22NW, LP | 31 Mar, 2026 | 492,759 | -430,920 | -46.65% | $4,129,320.00 |
| Northern Trust Corp | 31 Mar, 2026 | 393,640 | 19,951 | 5.34% | $3,298,703.00 |
| Stifel Financial Corp | 31 Mar, 2026 | 392,769 | 57,723 | 17.23% | $3,291,423.00 |